This discussion provides helpful approaches for Chief Medical Officers (CMOs) and other R&D leadership in biotech on how to communicate effectively in times of good, bad or unexpected news. Also discussed in this program are factors to evaluate for the discontinuation of a program. Dr Mark Weinberg, Chief Medical Officer and Managing Director of Halloran Consulting Group will be joined by Dr Lee Allen, CMO, Argos Therapeutics to discuss strategic communication strategies CMOs/R&D leadership can utilize to effectively deliver unexpected or difficult news.

More specifically:

How do you communicate successfully?
How does a CMO manage an unexpected realization?
Tips on being an advocate and skeptic for your programs
Flexibility and decision making with data
Scenario planning
Tips on communicating to the public
Evaluating factors for discontinuing a program
Rationalizing your portfolio? Who decides?

Guests:

Lee Allen, MD, PhD, CMO, Argos Therapeutics

Mark Weinberg, MD, MBA, CMO and Managing Director, Halloran Consulting Group

Producer:

Valerie Bowling, Executive Director, PharmaTalk Radio & The Conference Forum

Recommended Conference: The CMO and R&D Biotech Leadership Summit, Nov 14-15 in San Francisco. For more info:

http://theconferenceforum.org/conferences/rdbiotechleadershipsummit/overview/

Communicating the Good, Bad & Ugly for CMOs and R&D Leaders in Biotech

Share

Embed